A patient with recalcitrant oral pemphigus vulgaris successfully treated with a biologic drug- Rituximab
Pemphigus vulgaris (PV) is a chronic autoimmune blistering disease affecting mucous membranes and the skin. Rituximab (RTX), a monoclonal antibody against CD20, has been approved by FDA for the treatment of adults with moderate to severe PV. A 42-year-old Indian woman, previously diagnosed with oral...
I tiakina i:
| Ngā kaituhi matua: | , , |
|---|---|
| Hōputu: | Online |
| Reo: | Ingarihi |
| I whakaputaina: |
International Association for Dental Research (Nigeria Division)
2019
|
| Urunga tuihono: | https://ajoh.oauife.edu.ng/index.php/ajoh/article/view/41 |
| Tags: |
Tāpirihia he Tūtohu
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!